Your Trusted Science-backed Resource for Health, Nutrition and Lifestyle Medicine since 2012
Dutch 'dementia village' that offers beer, bingo, and top-notch healthcare
Get link
Facebook
X
Pinterest
Email
Other Apps
By
Editorial Team
-
Residents of Hogeweyk, a village located in Weesp, Netherlands, lead a normal life. They go to the grocery store, complain about the weather, and enjoy a weekly game of bingo.
But there's one thing that sets the 152 residents apart from the general public: Everyone has an advanced form of dementia.
Hogeweyk is a nursing home disguised to look like the outside world. It helps people with mild to severe dementia suffer a little bit less in their remaining years, facility manager Eloy van Hal told Business Insider. He said it preserves people's sense of autonomy.
The village is comprised of 23 houses, each with six to seven residents and a caregiver who cooks, takes people to social events, helps them go grocery shopping at the village market, and watches over them to ensure their safety.
Here's what life is like inside Hogeweyk's walls.
Hogeweyk started in 1993 as your typical hospital-style nursing home. But the staff soon realized there was a better, more humane, way to offer care.
Hogewey
"We said to each other 'What do we want for ourselves and our moms and dads?" van Hal said.
The consensus was that people wanted normalcy, at least to the extent caregivers could provide it. Gradually, Hogeweyk began folding in elements of the outside world. It started by creating 23 houses in four different "lifestyle" categories — cosmopolitan, nature-oriented, well-to-do, and traditional Dutch.
"You have to choose," van Hal said. "Which is the lifestyle according to your preferences?"
Staff at Hogeweyk are trained to focus on highlighting what residents can do, not what they can't.
Hogewey
Hogeweyk places a great deal of importance on word choice, van Hal said. The staff members don't treat patients — they care for residents.
"All the residents living here need medical treatment, yes. They all have medication. They all have [an] advanced stage of dementia," van Hal said. "But they are first a person. That's why there are people living here with dementia, and not demented people."
Hogeweyk caregivers and house attendants use an in-house currency to help their residents buy groceries at a fully-functional supermarket.
Hogewey
The residents can also use real money if they want to, Hal said. Only a handful are lucid enough to do so, and typically they spend it on small items like toothpaste and candy bars.
As part of the facility's normal budgeting process, a chunk of money (not real currency) is doled out to each of the 23 houses. With some help from the caregivers, it's up to the houses to budget the money how they see fit over the course of the month.
"For us it's important that we support them to experience a normal day, a day they like and a day they recognize," van Hal said.
Hogewey
As a matter of policy, Hogeweyk rejects the idea that people with dementia ought to miss out on the finer things, such as beer or wine — even if they don't follow the social norms that most other people do.
"They have really bad manners and habits, in food and behavior," he said. "We are not going to change that."
Residents can use real money at the facility's pub. If people display signs of alcohol abuse, however, the facility will not serve them.
The staff of medical professionals tries to cater to each resident based on their unique needs, van Hal said.
Hogewey
That's important for a sensitive disease like dementia, he added. There are roughly 50 million people worldwide living with dementia, which means there are an equivalent number of stages at which the disease has advanced.
It's up to the Hogeweyk staff to know which residents are more lucid than others, and to treat them accordingly if they slip up with a name or date. According to van Hal, there is no single policy for bringing residents back into "the real world" or letting them live in their bubble.
Although certain homes are designed to accommodate introverts, there are a variety of social events available to residents, van Hal said. There are also bingo nights, social clubs, theater events, and plenty of chances to bump into neighbors.
Hogewey
Research has found that loneliness is just as deadly as smoking and twice as lethal as obesity. As seniors tend to be the age group that most often lives by themselves, Hogeweyk feels a responsibility to make sure people get as much social interaction as they require.
"You are busy, you are outside, you can complain about the weather," he said.
It's also important for residents to go outside, research has found. Hogewey tries to encourage residents to take walks or enjoy one of the several gardens.
Hogewey
Alzheimer's and dementia sufferers are widely encouraged to stay physically active to keep their minds and bodies engaged.
Residents at Hogewey can stroll through the open courtyard or help caregivers tend to one of the many gardens. Even just sitting on a bench in the outdoors can help improve their mood and overall well-being, research has found.
The efforts may only yield benefits for a few years. But van Hal said the small details can mean the most, even if it's just pouring a resident the perfect cup of coffee.
Hogewey
"If we know that you have sugar in your coffee, we will still ask you every day, 'Do you want sugar in your coffee?' so you can make that choice every day," van Hal said. "That you can still decide what you put in your coffee is important."
Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer . 2025 studies on ivermectin for cancer Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer (ASCO 2025) Yuwen et al - A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ive...
Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories (46 cases) Brain Cancer (including Glioblastoma) (7 cases) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories (7 cases) Cervical Cancer (2 cases) Colorectal Cancer (29 cases) Esophageal and Stomach cancer (9 cases) Endometrial Cancer (6 cases) Gastric (Stomach) cancer (refer to Esophageal and Stomach Cancer ) Head and Neck Cancer (12 cases) Kidney Cancer Case Series (12 cases) Liver Cancer (HepatoCellular Cancer) (3 cases) Lung Cancer (20 cases) Leukemia (2 cases) Lymphoma (10 cases) Melanoma (refer to Skin Cancer ) Multiple Myeloma (3 cases) Myelodysplastic Syndrome Oral Cancer Ovarian Cancer (5 cases) Pancreatic Cancer (23 cases) Pro...
We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024. Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. Journal of Orthomolecular Medicine 2024 Targeting the Mitochondri...
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories . We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with ...
Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer treatment. Commonly available information about ivermectin dosages is often inaccurate when applied to potential cancer-related uses. Many sources cite standard dosages recommended by Merck for treating parasitic infections, rather than dosages studied specifically in the context of cancer research. The anti-parasitic dosage is not as effective for people looking for a dosage against cancer. Dosage will need to be adjusted according to cancer type and stage. Ivermectin dosage should be based on ivermectin cancer studies. Multiple factors are considered including studies including ivermectin for cancer, anecdotal studies and case series, the aggressiveness of the cancer type and the cancer stage. Cancer dosage estimation can be adjusted based on the time that a person has to beat cancer or its risk to the patient - this includes both the cancer type and whether the ca...
A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin. Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration. The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial. Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias. Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy: ...
In 2022, Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. (1) “I decided that I will make that decision,” she said, “only if it’s the last resort, and I’m on my deathbed.” A few months before her consultation, however, Eyres, then fifty-eight, made an appointment with a new primary care doctor for routine prescription refills. She was about to be introduced, literally and figuratively, to a new kind of medicine. It would change everything. Dr. James Miller, a former surgeon, liked to get to know his patients, so he asked Eyres for her history. She told him of her diagnosis, thirty years prior, with a serious but manageable case of scleroderma. In 2020, however, this auto-immune disorder, which can affect skin and organs...
Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (1) Fenbendazole, has garnered attention for its potential use in humans. The Fenbendazole Cancer Protocol gained rapid interest over the past years following some fenbendazole advanced cancer success stories . Joe Tippens founded the protocol after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists...
Introduction Prostate cancer remains a significant health challenge globally, particularly in its advanced stages where treatment resistance and disease progression limit patient outcomes. Despite advances in targeted therapies, hormone therapies, and immunotherapies, many patients with metastatic or recurrent prostate cancer face a need for new, more effective treatment options. Testosterone suppressant drugs such as leuprolide injections and apalutamide pills are used until the cancer no longer responds to hormone suppression, a state referred to as loss of hormone sensitivity. One of the most significant side effects of leuprolide injections is bone demineralization, which can occur at a high rate of up to 11% per year. Enzalutamide and abiraterone are commonly used to treat various subtypes of prostate cancer, with treatment and monitoring tailored to each specific subtype. The primary subtypes treated with these agents are metastatic hormone-sensitive prostate cancer (...
Breast cancer remains one of the most challenging and prevalent malignancies worldwide, with metastatic and treatment-resistant cases posing significant therapeutic hurdles. Conventional treatment options, including chemotherapy, targeted therapies, and immunotherapy, often reach their limits, particularly in advanced stages such as triple-negative breast cancer (TNBC). For patients with actionable mutations identified through molecular profiling, targeted therapies are the preferred treatment approach. In particular, for estrogen receptor–positive (ER+) breast cancer patients with a low Oncotype DX recurrence score, hormonal therapy alone is often appropriate, as genomic testing indicates a low risk of cancer recurrence and supports de-escalation of more aggressive systemic treatments. The preference for targeted treatments reflects their demonstrated efficacy in improving outcomes in these molecularly defined subgroups, underscoring the importance of comprehensive genomic profil...
Comments
Post a Comment